Assessing Pancreatic Ductal Adenocarcinoma Vascular Invasion: the PDACVI Benchmark
Authors: M. Riera-Marín, O. K. Sikha, J. Rodríguez-Comas, M. S. May, T. Kirscher, X. Coubez, P. Meyer, S. Faisan, +18 more
Organizations: BCN Medtech, Universitat Pompeu Fabra, Barcelona, Spain · Universitätsklinikum Erlangen, Department of Radiology of the Uniklinikum Erlangen (UKER), Erlangen, Germany · University Hospital Erlangen, Imaging Science Institute, Erlangen, Germany · ICUBE Laboratory, CNRS UMR-7357, University of Strasbourg, Strasbourg, France · CLCC Institut-Strauss, Strasbourg, France · Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China · University of Chinese Academy of Sciences, Beijing, China · Universit´e de Rennes 1, CLCC Eug`ene Marquis, and INSERM UMR 1099 LTSI, Rennes, France · German Cancer Research Center (DKFZ), Medical Image Computing (E230), Heidelberg, Germany · Hospital de Sant Pau i la Santa Creu, Diagnostic Imaging Department, Barcelona, Spain · Institut de Recerca Sant Pau - CERCA, Advanced Medical Imaging, Artificial Intelligence, and Imaging-Guided Therapy Research Group, Barcelona, Spain · Instituci´o Catalana de Recerca i Estudis Avan¸ats (ICREA), Barcelona, Spain · TECNALIA, Basque Research and Technology Alliance (BRTA), Bizkaia, Spain
Surgical resection remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC), and eligibility depends on accurate assessment of vascular invasion (VI), i.e., tumor extension into adjacent critical vessels. Despite its importance for preoperative staging and surgical planning, computational VI assessment remains underexplored. Two major challenges are the lack of public datasets and the diagnostic ambiguity at the tumor-vessel interface, which leads to substantial inter-rater variability even among expert radiologists. To address these limitations, we introduce the CURVAS-PDACVI Dataset and Challenge, an open benchmark for uncertainty-aware AI in PDAC staging based on a densely annotated dataset with five independent expert annotations per scan. We also propose a multi-metric evaluation framework that extends beyond spatial overlap to include probabilistic calibration and VI assessment. Evaluation of six state-of-the-art methods shows that strong global volumetric overlap does not necessarily translate into reliable performance at clinically critical tumor-vessel interfaces. In particular, methods optimized for binary segmentation perform competitively on average overlap metrics, but often degrade in high-complexity cases with low expert consensus, either collapsing in volume or overextending at uncertain boundaries. In contrast, methods that model inter-rater disagreement produce better calibrated probabilistic maps and show greater robustness in these ambiguous cases. The benchmark highlights the limitations of volumetric accuracy as a proxy for localized surgical utility, motivating uncertainty-aware probabilistic models for preoperative decision-making.
Accurate determination of pancreatic ductal adenocarcinoma (PDAC) resectability relies on evaluating how the tumor interacts with major peripancreatic vessels on CT imaging, yet expert assessment often shows substantial variability. We introduce a fully automated multimodal deep learning framework that jointly analyzes 3D contrast enhanced CT and structured clinical information to classify patients into the three National Comprehensive Cancer Network (NCCN) resectability categories (upfront resectable, borderline resectable, locally advanced). The approach uses a Swin-UNETR backbone to obtain anatomy aware image representations through auxiliary segmentation of pancreas, tumor, and vascular structures. These features are fused with a compact clinical embedding derived from 17 routinely collected variables and processed by a lightweight classification head. Model training is guided by a dynamic multitask objective that adapts the balance between segmentation and classification based on current tumor Dice performance, promoting feature representations that remain both anatomically informed and discriminative.
Vincent Ochs, Christoph Kuemmerli, Florentin Bieder +12
Pancreatic ductal adenocarcinoma (PDAC) segmentation on contrast-enhanced CT is inherently ambiguous: inter-rater disagreement among experts reflects genuine uncertainty rather than annotation noise. Standard deep learning approaches assume a single ground truth, producing probabilistic outputs that can be poorly calibrated and difficult to interpret under such ambiguity. We present TwinTrack, a framework that addresses this gap through post-hoc calibration of ensemble segmentation probabilities to the empirical mean human response (MHR) -the fraction of expert annotators labeling a voxel as tumor. Calibrated probabilities are thus directly interpretable as the expected proportion of annotators assigning the tumor label, explicitly modeling inter-rater disagreement. The proposed post-hoc calibration procedure is simple and requires only a small multi-rater calibration set. It consistently improves calibration metrics over standard approaches when evaluated on the MICCAI 2025 CURVAS-PDACVI multi-rater benchmark.
Tristan Kirscher, Alexandra Ertl, Klaus Maier-Hein +3
Postoperative pancreatic fistula (POPF) is a serious complication after pancreatic resection, increasing morbidity, hospital stay, and healthcare costs. We present an automatic, end-to-end deep learning pipeline-from pancreatic segmentation to classification-for preoperative POPF risk estimation and stratification using preoperative CT scans. A data set with auto-segmented pancreas volumes and surgical outcomes was used to evaluate multiple architectures, including a custom lightweight 3D CNN baseline (CNN3D), R(2+1)D ResNet-18, and ResNet-MC3-18 models. Evaluation across multiple 3D architectures demonstrated promising predictive performance. This approach offers a clinically valuable tool and a methodological benchmark for pancreas-specific CT classification, supporting improved preoperative decision-making in pancreatic surgery.